AstaReal(R) Astaxanthin Effective in Reducing both Mental and Physical Fatigue in Clinical First

Food and Healthcare Press Releases Monday November 7, 2016 09:15
SINGAPORE--7 Nov--PRNewswire/InfoQuest
A new study published in the Journal of Clinical Therapeutics & Medicines has demonstrated that AstaReal(R) astaxanthin was simultaneously effective against both mental and physical fatigue.
http://photos.prnasia.com/prnvar/20161102/8521607132LOGO

Dr. Robert Corish, AstaReal's medical advisor, explained "This trial evaluated the most common type of fatigue that most of us experience during our daily routines; both mental fatigue and physical fatigue. The results show that AstaReal(R) astaxanthin suppresses and fights both types of fatigue and improves performance. Fatigue is the most common complaint heard by physicians today; and in my experience, this is the first time that a natural ingredient has been shown to improve this common condition."

In a double-blind, randomized placebo-controlled study, thirty-nine healthy subjects who had reported awareness of fatigue   were treated with AstaReal(R) astaxanthin for eight weeks. The study was designed to induce fatigue and stress, similar to that encountered in daily life. For the mental challenge, individuals were subjected to a battery of timed calculations (the Uchida-Kraepelin test) - a test requiring intense concentration. The physical component was performed using a bicycle ergometer. Objective and subjective metrics of fatigue were assessed both before and after the stressor tests.

Visual Analogue Scale (VAS) analysis showed that AstaReal(R) astaxanthin significantly improved clarity of thinking, concentration, motivation and mood compared to placebo. In the calculation test, an increase in errors observed in the placebo during the second half of the test was almost eliminated in the astaxanthin group. Supplementation with astaxanthin also significantly reduced salivary cortisol, a biomarker for stress.

Vincent Wood, President of AstaReal Singapore, stated, "We all require both physical and mental endurance as part of our daily lives. Supplements containing AstaReal(R) could be especially beneficial for people who work under high levels of physical and mental stress such as military and hospitality personnel and healthcare and financial professionals."

Reference:

Hongo, N. et al. "Randomized controlled trial of the anti-fatigue effects of astaxanthin on mental and physical loads simulating daily life." Journal of Clinical Therapeutics & Medicines 32.7 (2016): 277-91.

About AstaReal

AstaReal is part of the AstaReal Group, which is fully owned by Fuji Chemical Group of Japan. AstaReal(R) is the global brand name for its natural astaxanthin products. Visit www.astareal.sg for more information.

Further information:
Vincent Wood,
President AstaReal Pte Ltd.
enquiry@astareal.sg
+65 6222 1778
Logo - http://photos.prnasia.com/prnh/20161102/8521607132LOGO

Latest Press Release

Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease

-- Overall response rate exceeded specified study midpoint target (n=25); company elects to discontinue further patient enrollment as allowed by protocol -- Mallinckrodt plc (NYSE:MNK), a leading global specialty pharmaceutical company, today announced...

Takeda, Microsoft and EURORDIS release report with action plan to help rare disease community shorten the diagnostic odyssey

- Global Commission's recommendations focus on three solution pathways that leverage technology to address key elements of the rare disease diagnostic odyssey - Rare diseases remain undiagnosed as patients struggle to navigate complex health systems to...

Pivotal Phase III Data for BAVENCIO(R) (avelumab) Plus INLYTA(R) (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine

- JAVELIN Renal 101 shows significant improvement in progression-free survival with a hazard ratio of 0.69 in patients regardless of PD-L1 expression - US FDA has granted Priority Review to BAVENCIO plus INLYTA for patients with advanced renal cell...

ISABS เตรียมจัดการประชุมว่าด้วยการแพทย์ส่วนบุคคลที่โครเอเชีย พร้อมเชิญเจ้าของรางวัลโนเบลร่วมบรรยาย

International Society for Applied Biological Sciences (ISABS) ร่วมกับ Mayo Clinic และ St. Catherine Hospital เตรียมจัดการประชุม "ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ครั้งที่ 11...

ISABS: Personalized Medicine Conference With Nobel Laureates to Be Held in Split, Croatia

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital are organizing "11th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine"(http://www.isabs.net)...

Related Topics